Clinical Trial Update: The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of insulin degludec/liraglutide in adults with type 2 diabetes inadequately controlled on GLP-1 RA and oral antidia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Degludec/Liraglutide

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2018-07-09